Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature

Abdul Hamid Bazarbachi, MD, Herve Avet-Loiseau, Zachary R Hunter, PhD, Raphael Szalat, Anil Aktas-Samur, PhD, Masood A. Shammas, PhD, Jill Corre, PharmD, PhD, Mariateresa Fulciniti, PhD, Kenneth Anderson, MD, Giovanni Parmigiani, PhD, Steven Treon, Mohamad Mohty, MD PhD, Mehmet K. Samur, PhD, Nikhil C. Munshi, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-138951

Published: 2020

Journal Articles

High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma

Mehmet K. Samur, PhD, Marco Roncador, MD MSc, Anil Aktas-Samur, PhD, Mariateresa Fulciniti, PhD, Abdul Hamid Bazarbachi, MD, Raphael Szalat, Masood A. Shammas, PhD, Adam S Sperling, MD PhD, Paul G. Richardson, MD, Florence Magrangeas, Stephane Minvielle, PhD, Anjan Thakurta, Aurore Perrot, Jill Corre, PharmD, PhD, Philippe Moreau, MD, Kenneth Anderson, MD, Giovanni Parmigiani, PhD, Herve Avet-Loiseau, Nikhil C. Munshi, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-139014

Published: 2020

Journal Articles

High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma

Anil Aktas-Samur, PhD, Mariateresa Fulciniti, PhD, Sanika Derebail, MS, Raphael Szalat, Giovanni Parmigiani, PhD, Jill Corre, PharmD, PhD, Herve Avet-Loiseau, Mehmet K. Samur, PhD, Nikhil C. Munshi, MD

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-139066

Published: 2020

Journal Articles

Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study

Anil Aktas Samur, PhD, Mariateresa Fulciniti, PhD, Raphael Szalat, Jill Corre, PharmD, PhD, Niccolo Bolli, MD PhD, Philippe Moreau, MD, Michel Attal, MD PhD, Kenneth C. Anderson, MD, Giovanni Parmigiani, PhD, Hervé Avet-Loiseau, MD PhD, Mehmet Kemal Samur, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 3089.

https://doi.org/10.1182/blood-2019-128570

Published: 2019

Journal Articles

The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma

Mehmet Kemal Samur, PhD, Anil Aktas Samur, PhD, Tessa Han, Marco Roncador, MD MSc, Mariateresa Fulciniti, PhD, Raphael Szalat, Masood A. Shammas, PhD, Jill Corre, PharmD, PhD, Paul G. Richardson, MD, Florence Magrangeas, Stephane Minvielle, PhD, Philippe Moreau, MD, Michel Attal, MD PhD, Anjan Thakurta, Kenneth C. Anderson, MD, Giovanni Parmigiani, PhD, Herve Avet-Loiseau, MD PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 3055.

https://doi.org/10.1182/blood-2019-128521

Published: 2019

Journal Articles

Genome Wide Transcriptomic Analysis Identifies Dysregulated Splicing Factor Profile with Molecular and Functional Role in Multiple Myeloma

Anil Aktas Samur, PhD, Mehmet Kemal Samur, PhD, Michael A Lopez, Sanika Derebail, Kenneth C. Anderson, MD, Herve Avet-Loiseau, MD PhD, Giovanni Parmigiani, PhD, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 361.

https://doi.org/10.1182/blood-2019-129114

Published: 2019

Journal Articles

Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma

Tessa Han, Stephane Minvielle, PhD, Anil Aktas Samur, PhD, Mariateresa Fulciniti, PhD, Florence Magrangeas, PhD, Paul G. Richardson, MD, Philippe Moreau, MD, Michel Attal, MD PhD, Kenneth C. Anderson, MD, Hervé Avet-Loiseau, MD PhD, Giovanni Parmigiani, PhD, Mehmet Kemal Samur, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4348.

https://doi.org/10.1182/blood-2019-130343

Published: 2019

Journal Articles

A Detailed Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications

Anil Aktas Samur, PhD, Mehmet Kemal Samur, PhD, Stephane Minvielle, PhD, Florence Magrangeas, Mariateresa Fulciniti, PhD, Raphael Szalat, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Michel Attal, Philippe Moreau, Giovanni Parmigiani, PhD, Herve Avet-Loiseau, MD PhD, Nikhil C Munshi, MD

Blood (2016) 128 (22): 356.

https://doi.org/10.1182/blood.V128.22.356.356

Published: 2016

Journal Articles

RNA-Seq De Novo Assembly of Clonal Immunoglobulin Rearrangements Identifies Interesting Biology and Uncovers Prognostic Features in Multiple Myeloma

David Mosen-Ansorena, PhD, Rachael Bashford-Rogers, PhD, Niccolo Bolli, MD, Stephane Minvielle, PhD, Florence Magrangeas, Kenneth C Anderson, MD, Herve Avet-Loiseau, MD PhD, Giovanni Parmigiani, PhD, Nikhil C Munshi, MD

Blood (2016) 128 (22): 195.

https://doi.org/10.1182/blood.V128.22.195.195

Published: 2016

Journal Articles

The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for the Clinical Classification of Multiple Myeloma

Brian A Walker, PhD, Mehmet K. Samur, PhD, Konstantinos Mavrommatis, Cody Ashby, PhD, Christopher P Wardell, PhD, Maria Ortiz, PhD, Fadi Towfic, Caleb K. Stein, MS, Michael A Bauer, PhD, Michael Amatangelo, PhD, Giovanni Parmigiani, PhD, Zhinuan Yu, PhD, Matthew Trotter, Herve Avet-Loiseau, MD PhD, Graham H Jackson, MD PhD, Kenneth C. Anderson, Anjan Thakurta, PhD, Nikhil C. Munshi, MD, Gareth J Morgan, MD PhD

Blood (2016) 128 (22): 196.

https://doi.org/10.1182/blood.V128.22.196.196

Published: 2016

Journal Articles

3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome

Mehmet K. Samur, PhD, Irtisha Singh, Lee Shih-Han, Adam Samuel Sperling, MD PhD, Mariateresa Fulciniti, PhD, Yu-Tzu Tai, PhD, Giovanni Parmigiani, PhD, Christina S. Leslie, PhD, Christine Mayr, Nikhil C Munshi, MD

Blood (2016) 128 (22): 4447.

https://doi.org/10.1182/blood.V128.22.4447.4447

Published: 2016

Journal Articles

Differentially Expressed and Prognostically Significant Lincrnas May Impact Immune System and Tumor Progression in Multiple Myeloma (MM)

Mehmet K Samur, PhD, Annamaria Gulla, MD, Alice Cleynen, PhD, Florence Magrangeas, Stephane Minvielle, Kenneth C Anderson, Giovanni Parmigiani, PhD, Hervé Avet-Loiseau, MD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 2989.

https://doi.org/10.1182/blood.V126.23.2989.2989

Published: 2015

Journal Articles

Functional and Clinical Impact of Splicing Factor Dysregulation in Multiple Myeloma

Mariateresa Fulciniti, Mehmet Kemal Samur, PhD, Naim Ur Rashid, PhD, Rajya Lakshmi Bandi, MS, Manoj Bhasin, PhD, Giovanni Parmigiani, PhD, Kenneth C Anderson, MD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 726.

https://doi.org/10.1182/blood.V126.23.726.726

Published: 2015

Journal Articles

Genomic Landscape Predictive of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)

Mehmet K Samur, PhD, Stephane Minvielle, Florence Magrangeas, Giovanni Parmigiani, PhD, Kenneth C Anderson, Philippe Moreau, MD, Michel Attal, Hervé Avet-Loiseau, MD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 4212.

https://doi.org/10.1182/blood.V126.23.4212.4212

Published: 2015

Journal Articles

The Fusion Gene Landscape in Multiple Myeloma, with Clinical Impact

Alice Cleynen, PhD, Raphaël Szalat, MD, Mehmet Kemal Samur, PhD, Giovanni Parmigiani, PhD, Nikhil C. Munshi, MD, Hervé Avet-Loiseau, MD

Blood (2015) 126 (23): 835.

https://doi.org/10.1182/blood.V126.23.835.835

Published: 2015

Journal Articles

Redefining Mutational Profiling Using RNA-Seq: Insight into the Functional Mutational Landscape of Multiple Myeloma

David Mosen-Ansorena, PhD, Niccolo Bolli, MD, Mehmet K Samur, PhD, Florence Magrangeas, Stephane Minvielle, Kenneth C Anderson, MD, Peter J Campbell, MD PhD, Hervé Avet-Loiseau, MD, Giovanni Parmigiani, PhD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 837.

https://doi.org/10.1182/blood.V126.23.837.837

Published: 2015

Journal Articles

Identification of a Novel Long Intergenic Noncoding RNA - Linc00936, with Significant Impact on Multiple Myeloma Cell Growth Via mTOR Pathway Inhibition

Annamaria Gulla, MD, Mehmet Kemal Samur, PhD, Mariateresa Fulciniti, PhD, Masood A Shammas, PhD, Teru Hideshima, MD, PhD, Pierosandro Tagliaferri, MD, Giovanni Parmigiani, PhD, Pierfrancesco Tassone, MD, Kenneth C Anderson, MD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 504.

https://doi.org/10.1182/blood.V126.23.504.504

Published: 2015

Journal Articles

Nuclease Activity Is Associated with Genomic Instability As Well As Survival in Myeloma; Underlying Mechanisms and Significance

Masood A Shammas, PhD, Leutz Buon, Jianhong Lin, MD M.Sc, Mehmet K Samur, PhD, Jaymin M. Patel, MD, Ankit Vahia, Purushothama Nanjappa, Subodh Kumar, PhD, Ahsun Bajwa, Humza Ahmad, David Alagpulinsa, BPham, Giovanni Parmigiani, PhD, Florence Magrangeas, Stephane Minvielle, Herve Avet-Loiseau, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 2420.

https://doi.org/10.1182/blood.V126.23.2420.2420

Published: 2015

Journal Articles

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Adam Sperling, MD PhD, Naim Rashid, PhD, Niccolo Bolli, MD PhD, David Wedge, PhD, Peter Van Loo, PhD, Yu-Tzu Tai, Masood Shammas, PhD, Mariateresa Fulciniti, PhD, Mehmet Kemal Samur, PhD, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, P Andrew Futreal, Kenneth C. Anderson, Herve Avet-loiseau, Peter J. Campbell, PhD, Giovanni Parmigiani, PhD, Nikhil Munshi

Blood (2014) 124 (21): 2007.

https://doi.org/10.1182/blood.V124.21.2007.2007

Published: 2014

Journal Articles

Nucleotide Excision Repair (NER) Is Frequently Impaired and Affects Outcome in Multiple Myeloma (MM)

Raphael Szalat, MD, Matija Dreze, PhD, Mehmet Kemal Samur, PhD, Anne S. Calkins, MDcal student, Giovanni Parmigiani, PhD, Herve Avet-Loiseau, Kenneth C. Anderson, MD, Jean-Paul Fermand, MD PhD, Jean-Bernard Lazaro, PhD, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 2055.

https://doi.org/10.1182/blood.V124.21.2055.2055

Published: 2014

NARROW

Genomic and Transcriptomic Characterization of IgM Multiple Myeloma Identifies a Pre-Germinal Center Plasma Cell Disorder with Immature B-Cell Transcription-Factor Signature

High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma

High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma

Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study

The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma

Genome Wide Transcriptomic Analysis Identifies Dysregulated Splicing Factor Profile with Molecular and Functional Role in Multiple Myeloma

Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma

A Detailed Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications

RNA-Seq De Novo Assembly of Clonal Immunoglobulin Rearrangements Identifies Interesting Biology and Uncovers Prognostic Features in Multiple Myeloma

The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for the Clinical Classification of Multiple Myeloma

3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome

Differentially Expressed and Prognostically Significant Lincrnas May Impact Immune System and Tumor Progression in Multiple Myeloma (MM)

Functional and Clinical Impact of Splicing Factor Dysregulation in Multiple Myeloma

Genomic Landscape Predictive of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)

The Fusion Gene Landscape in Multiple Myeloma, with Clinical Impact

Redefining Mutational Profiling Using RNA-Seq: Insight into the Functional Mutational Landscape of Multiple Myeloma

Identification of a Novel Long Intergenic Noncoding RNA - Linc00936, with Significant Impact on Multiple Myeloma Cell Growth Via mTOR Pathway Inhibition

Nuclease Activity Is Associated with Genomic Instability As Well As Survival in Myeloma; Underlying Mechanisms and Significance

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Nucleotide Excision Repair (NER) Is Frequently Impaired and Affects Outcome in Multiple Myeloma (MM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only